Acid inhibition on the first day of dosing: comparison of four proton pump inhibitors von Pantoflickova, D., Dorta, G., Ravic, M., Jornod, P., Blum, A. L.

Volltext

Phase I and Pharmacokinetic Study of E7070, a Novel Chloroindolyl Sulfonamide Cell-Cycle Inhibitor, Administered as a One-Hour Infusion Every Three Weeks in Patients With Advanced... von RAYMOND, E, TEN BOKKEL HUININK, W. W, TAÏEB, J, BEIJNEN, J. H, FAIVRE, S, WANDERS, J, RAVIC, M, FUMOLEAU, P, ARMAND, J. P, SCHELLENS, J. H. M

Volltext

Phase II study of E7070 in patients with metastatic melanoma von Smyth, J. F., Aamdal, S., Awada, A., Dittrich, C., Caponigro, F., Schöffski, P., Gore, M., Lesimple, T., Djurasinovic, N., Baron, B., Ravic, M., Fumoleau, P., Punt, C. J. A.

Volltext

The effects of chronic, dose-dependent administration of dronedarone and amiodarone on cardiodynamics and oxidative stress parameters of isolated rat heart with hypertension von Simovic, S, Jeremic, J, Srejovic, I, Davidovic, G, Zivkovic, V, Mitrovic, S, Nikolic, M, Ravic, M, Andjic, M, Rankovic, M, Draginic, N, Jakovljevic, V

Volltext

Population Pharmacokinetics of the Novel Anticancer Agent E7070 During Four Phase I Studies: Model Building and Validation von VAN KESTEREN, Ch, MATHOT, R. A. A, WANDERS, J, BEIJNEN, J. H, FUMOLEAU, P, SCHELLENS, J. H. M, RAYMOND, E, ARMAND, J. P, DITTRICH, Ch, DUMEZ, H, ROCHE, H, DROZ, J. P, PUNT, C, RAVIC, M

Volltext

Phase I clinical and pharmacokinetic study of E7070, a novel sulfonamide given as a 5-day continuous infusion repeated every 3 weeks in patients with solid tumours. A study by the... von Terret, C, Zanetta, S, Roché, H, Schellens, J.H.M, Faber, M.N, Wanders, J, Ravic, M, Droz, J.P

Volltext

Phase I and pharmacokinetic study of E7070, a novel sulfonamide, given at a daily times five schedule in patients with solid tumors. A study by the EORTC-Early Clinical Studies Gro... von Punt, C. J. A., Fumoleau, P., van de Walle, B., Faber, M. N., Ravic, M., Campone, M.

Volltext

P561Acute effects of dronedarone and amiodarone on functional, morphological and oxidative stress parameters in isolated rat heart with hypertension von Simovic, S, Jeremic, J, Davidovic, G, Srejovic, I, Mitrovic, S, Zivkovic, V, Ravic, M, Miloradovic, V, Nikolic, M, Vucic, R, Andjic, M, Rankovic, M, Draginic, N, Jakovljevic, V

Volltext

The dose-dependent effect of chronic Verapamil treatment on cardiac function in isolated rat heart with Hypertension von Simovic, S, Jeremic, J, Davidovic, G, Srejovic, I, Zivkovic, V, Ravic, M, Nikolic, M, Iric-Cupic, V, Vucic, R, Sreckovic, M, Miloradovic, V, Andjic, M, Rankovic, M, Draginic, N, Jakovljevic, V

Volltext

Safety and efficacy of 7‐day rabeprazole‐ and omeprazole‐based triple therapy regimens for the eradication of Helicobacter pylori in patients with documented peptic ulcer disease... von Hawkey, C. J., Atherton, J. C., Treichel, H. C., Thjodleifsson, B., Ravic, M.

Volltext

5,6-Dimethylxanthenone-4-Acetic Acid in the Treatment of Refractory Tumors: a Phase I Safety Study of a Vascular Disrupting Agent von MCKEAGE, Mark J, FONG, Peter, JEFFERY, Mark, BAGULEY, Bruce C, KESTELL, Phil, RAVIC, Miroslav, JAMESON, Michael B

Volltext

OLDER SUBJECTS WOULD MORE LIKELY USE SMARTPHONE APPLICATIONS FOR HYPERTENSION THAN MIDDLE-AGED PATIENTS. DATA FROM THE 2017 WORLD HYPERTENSION DAY IN CROATIA von Dapic, K., Domislovic, V., Milicic, B., Drenjacevic, I., Gulin, M., Grba, E., Cavrak, V. Herceg, Jelakovic, A., Josipovic, J., Kralj, V., Leko, N., Lugovic, N., Mrsic, M., Pavlovic, D., Prkacin, I., Radic, J., Ravic, M., Brinar, I. Vukovic, Zeljkovic Vrkic, T., Jelakovic, B.

Volltext

Recruit-Tandab AFM13 - Overcoming Limitations of Monoclonal Antibodies in Hodgkin Lymphoma von Zhukovsky, E., Ravic, M., Rothe, A., Topp, M., Younes, A., Knackmuss, S., Reusch, U., Rajkovic, E., Hucke, C., Little, M.

Volltext

1072P - Recruit-Tandab AFM13 - Overcoming Limitations of Monoclonal Antibodies in Hodgkin Lymphoma von Zhukovsky, E., Ravic, M., Rothe, A., Topp, M., Younes, A., Knackmuss, S., Reusch, U., Rajkovic, E., Hucke, C., Little, M.

Volltext

In vitro pharmacokinetic study of the novel anticancer agent E7070: red blood cell and plasma protein binding in human blood von van den Bongard, H. J. G. D, Pluim, D, Waardenburg, R. C. A. M van, Ravic, M, Beijnen, J. H, Schellens, J. H. M

Volltext

Phase I and Pharmacokinetic Study of E7070, a Chloroindolyl-Sulfonamide Anticancer Agent, Administered on a Weekly Schedule to Patients with Solid Tumors von DITTRICH, Christian, DUMEZ, Herlinde, CALVERT, Hilary, HANAUSKE, Axel, FABER, Marije, WANDERS, Jantien, YULE, Murray, RAVIC, Miroslav, FUMOLEAU, Pierre

Volltext

Development and validation of limited sampling strategies for prediction of the systemic exposure to the novel anticancer agent E7070 (N‐(3‐chloro‐7‐indolyl)‐1,4‐benzenedisulphonam... von Van Kesteren, Charlotte, Mathôt, R. A. A., Raymond, E., Armand, J. P., Fumoleau, P., Punt, C., Ravic, M., Wanders, J., Beijnen, J. H., Schellens, J. H. M.

Volltext

Population pharmacokinetics and pharmacokinetic‐pharmacodynamic relationships of the novel anticancer agent E7070 in four phase I studies von Van Kesteren, CH, Mathôt, R. A. A., Raymond, E., Armand, J. P., Dittrich, CH, Dumez, H., Roché, H., Droz, J. P., Punt, C., Ravic, M., Wanders, J., Beijnen, J. H., Fumoleau, P., Schellens, J. H. M.

Volltext

Renal and general tolerability of repeated doses of nimesulide in normal subjects von WARRINGTON, S. J, RAVIC, M, DAWNAY, A

Volltext

700 Results of a phase-1 dose escalation study of intravesical TMX-101 in patients with non-muscle invasive bladder cancer von Falke, J, Lammers, J.M, Arentsen, H.C, Ravic, M, Pozzi, R, Cornel, E.B, Vergunst, H, De Reijke, T.M, Witjes, J.A

Volltext